Clinical Trials
3 trialsNCT00924170 2023-11-14
Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT01000285 2017-03-28
ATLL
Washington University School of Medicine
Phase 1/2 Completed
NCT00001941 2012-08-20
Anti-Tac for Treatment of Leukemia
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed